Growth Metrics

Zimmer Biomet Holdings (ZBH) Liabilities and Shareholders Equity (2016 - 2026)

Zimmer Biomet Holdings has reported Liabilities and Shareholders Equity over the past 18 years, most recently at $22.7 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 2.42% year-over-year to $22.7 billion; the TTM value through Mar 2026 reached $92.2 billion, up 6.2%, while the annual FY2025 figure was $23.1 billion, 8.08% up from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $22.7 billion at Zimmer Biomet Holdings, down from $23.1 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $23.5 billion in Q3 2025 and troughed at $21.1 billion in Q4 2022.
  • A 5-year average of $21.8 billion and a median of $21.5 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: fell 11.44% in 2022 and later rose 8.14% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $21.1 billion in 2022, then grew by 2.05% to $21.5 billion in 2023, then dropped by 0.61% to $21.4 billion in 2024, then rose by 8.08% to $23.1 billion in 2025, then decreased by 1.6% to $22.7 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for ZBH at $22.7 billion in Q1 2026, $23.1 billion in Q4 2025, and $23.5 billion in Q3 2025.